valproic acid has been researched along with panobinostat in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Corey, DR; Sakurai, F; Yu, D | 1 |
| Forgione, M; Hailu, GS; Mai, A; Robaa, D; Rotili, D; Sippl, W | 1 |
| Brindisi, M; Brogi, S; Butini, S; Campiani, G; Gemma, S; Saraswati, AP | 1 |
| Alfano, AI; Barone, S; Brindisi, M; Cassese, E; Summa, V | 1 |
| Blümcke, I; Coras, R; Garbes, L; Hahnen, E; Hauke, J; Heller, R; Hölker, I; Riessland, M; Tränkle, C; Wirth, B | 1 |
| Biçaku, E; Marchion, DC; Münster, PN; Thomas, S; Thurn, KT | 1 |
| Agapova, OA; Bowcock, AM; Harbour, JW; Kneass, ZT; Landreville, S; Lee, RS; Matatall, KA; Onken, MD | 1 |
| Bug, G; Romanski, A | 1 |
| Beyer, M; Kiweler, N; Krämer, OH; Mahboobi, S | 1 |
| Figg, WD; Goey, AK; Peer, CJ; Sissung, TM | 1 |
| Baude, A; Blagitko-Dorfs, N; Brocks, D; Greve, G; Lübbert, M; Meier, R; Pfeifer, D; Plass, C; Schlosser, P | 1 |
3 review(s) available for valproic acid and panobinostat
| Article | Year |
|---|---|
Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives.
Topics: Animals; Antiparasitic Agents; Drug Repositioning; Helminth Proteins; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Leishmania; Plasmodium; Protozoan Proteins; Schistosoma; Toxoplasma; Trypanosoma | 2017 |
Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology.
Topics: Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Histone Deacetylase 6; Humans; Signal Transduction | 2022 |
Pharmacogenomics and histone deacetylase inhibitors.
Topics: Depsipeptides; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Panobinostat; Pharmacogenetics; Sulfonamides; Valproic Acid; Vorinostat | 2016 |
8 other study(ies) available for valproic acid and panobinostat
| Article | Year |
|---|---|
Clonal Rett Syndrome cell lines to test compounds for activation of wild-type MeCP2 expression.
Topics: Clone Cells; Epigenesis, Genetic; Fibroblasts; Gene Expression Profiling; Humans; Methyl-CpG-Binding Protein 2; Molecular Structure; Mutation; Organic Chemicals; Polymerase Chain Reaction; Rett Syndrome; RNA, Messenger; Stereoisomerism | 2011 |
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases.
Topics: Animals; Biomarkers; Cell Line; Epigenesis, Genetic; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Mice; Protein Processing, Post-Translational; Rare Diseases | 2020 |
LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate.
Topics: Animals; Cells, Cultured; Fibroblasts; Gene Expression; Humans; Hydroxamic Acids; Indoles; Mice; Mice, Knockout; Mice, Transgenic; Muscular Atrophy, Spinal; Panobinostat; Survival of Motor Neuron 2 Protein; Valproic Acid | 2009 |
Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Breast Neoplasms; Cell Line, Tumor; Drug Synergism; Estradiol; Estrogen Receptor alpha; Female; Gene Expression; Gene Knockdown Techniques; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Membrane Proteins; Microtubule-Associated Proteins; Panobinostat; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Signal Transduction; Tamoxifen; Valproic Acid; Vorinostat | 2011 |
Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.
Topics: Animals; Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Chemoradiotherapy, Adjuvant; Computer Simulation; Gene Knockdown Techniques; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Melanoma; Mice; Mice, Inbred NOD; Mice, SCID; Models, Biological; Neoplasm Micrometastasis; Panobinostat; Tumor Burden; Tumor Suppressor Proteins; Ubiquitin Thiolesterase; Uveal Neoplasms; Valproic Acid; Vorinostat; Xenograft Model Antitumor Assays | 2012 |
Establishment and Characterization of Long-Term Cultures Derived from Primary Acute Myeloid Leukemia Cells for HDAC Inhibitor Research.
Topics: Antigens, CD34; Apoptosis; Biomarkers, Tumor; Cell Culture Techniques; Cell Proliferation; Cell Separation; Cytokines; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Indoles; Inhibitor of Apoptosis Proteins; Leukemia, Myeloid, Acute; Neoplastic Stem Cells; Panobinostat; Primary Cell Culture; Signal Transduction; Survivin; Tumor Cells, Cultured; Valproic Acid; Vorinostat | 2017 |
How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.
Topics: Acetylation; Animals; Benzamides; Blotting, Western; Cell Line, Tumor; Epigenesis, Genetic; Epithelial Cells; Histone Deacetylase 1; Histone Deacetylase 2; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Indoles; Mice; Monocytes; Panobinostat; Protein Processing, Post-Translational; Pyridines; Valproic Acid | 2017 |
Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body demethylation.
Topics: Biomarkers, Tumor; Decitabine; Demethylation; DNA Methylation; DNA Modification Methylases; Down-Regulation; Drug Synergism; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Leukemia, Myeloid, Acute; Panobinostat; Valproic Acid | 2019 |